Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MLAB
MESA LABORATORIES, INC.
NASDAQ
$129.09
▲ UP 0.34% (0.44)

KEY STATISTICS

Market Cap$722.37 M
52w High$129.66
52w Low$58.83
Dividend Yield0.70%
FrequencyQuarterly
P/E13.03
Volume153.07K
Shares Out.5.60M

COMPANY

LEADERSHIP

Siddhartha C. Kadia
CHIEF EXECUTIVE
Siddhartha C. Kadia

COMPENSATION 2026

Salary$808,846
Stock Awards$4,700,017
Incentive Plan Pay$1,120,000
All Other Comp.$14,345
Total$6,643,208

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 29, 1984
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
717

PRICE TARGET

Target High$110.00
Target Low$110.00
Target Median$110.00
Target Consensus$110.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$61.63M
NOV
5
THU

PRICE

$129.09 ▲ UP 0.34% (+$0.44)
$127$128$1299:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM129.09

About Mesa Laboratories, Inc.

https://www.mesalabs.com ↗

Mesa Laboratories develops and sells life sciences tools and quality control products globally, serving industries like healthcare, pharmaceuticals, and research with sterilization, biopharmaceutical, calibration, and genomic solutions.

INDUSTRY

Medical - Specialties

A PRODUCT MESA LABORATORIES, INC. IS KNOWN FOR

DryCal Defender series calibrators
DryCal Defender series calibrators

Mesa's primary gas flow calibrators provide high-accuracy calibration for air sampling equipment, widely adopted by regulatory bodies like OSHA to ensure workplace safety.

COMPETITORS

COMPETITOR
MKSI COMPARE

Revenue by Products

IconPRODUCTQ2-2026Q3-2026Q4-2026Q1-2027
Sterilization and Disinfection Control$22.11M $24.91M ▲$29.14M ▲$24.5M ▼
Calibration Solutions$13.57M $14.07M ▲$13.56M ▼$13.29M ▼
Biopharmaceutical Development$13.92M $14.37M ▲$8.85M ▼$12.06M ▲
Clinical Genomics$11.14M $11.77M ▲$12.18M ▲$10.29M ▼

Revenue by Geography

MapREGIONQ2-2026Q3-2026Q4-2026Q1-2027
UNITED STATES$29.3M $29.89M ▲$30.06M ▲$29.74M ▼
Other$26.12M $29.59M ▲$29.61M ▲$24.96M ▼
CHINA$5.32M $5.64M ▲$4.06M ▼$5.44M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
106
LISTED HERE
25
RANKED BY POSITION SIZE
VTS.AX
0.00% · 168.5K
IWM
0.02% · 137.1K
FESM
0.15% · 78.8K
JSML
1.02% · 30.3K
PSC
0.14% · 29.3K
SCHA
0.01% · 26.4K
DFAT
0.02% · 26.2K
DES
0.14% · 24.9K
AVSC
0.05% · 12.6K
R2SC.L
0.02% · 10.9K
GSSC
0.11% · 9.1K
PRFZ
0.04% · 8.9K
AI
AIMS
0.89% · 6.2K
XRSU.L
0.02% · 5.0K
RSSL
0.02% · 2.5K
AFTY
0.97% · 1.7K
KDVD
2.14% · 1.4K
LITL
0.84% · 445
BUYO
0.32% · 422
SAWS
0.58% · 349
URTY
0.01% · 218
DM
DMRS
0.08% · 144
IVSS
0.05% · 120
RESM
0.03% · 15
EB
EBI
0.00% · 8

INSTITUTIONAL OWNERSHIP

SHARES OWNED
72.22%
HOLDERS
253
TOP 12 OF 253 · RANKED BY POSITION SIZE
Blackrock Inc.
803.5K sh · $69.72M
Long Path Partners LP
477.1K sh · $47.5M
Blackrock, Inc.
440.6K sh · $43.86M
Conestoga Capital Advisors, LLC
426.5K sh · $28.58M
Vanguard Group Inc
321.9K sh · $25.27M
Boston Partners
268.7K sh · $23.76M
Morgan Stanley
255.0K sh · $17.09M
Select Equity Group, L.P.
235.9K sh · $20.86M
Ranger Investment Management, L.P.
209.7K sh · $14.05M
Nine Ten Partners LP
207.5K sh · $16.04M
Aqr Capital Management LLC
203.7K sh · $20.28M
Geneva Capital Management LLC
191.4K sh · $12.82M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score3

INSIDER TRADES

★
DIRECTOR
Alltoft Jennifer Sadie
Purchase · 2.8K shares
2026-08-15
★
DIRECTOR
Alltoft Jennifer Sadie
Sale · 2.8K shares
2026-08-15
★
DIRECTOR
Ladiwala Shiraz Shabanali
Sale · 3.8K shares
2026-08-15
★
DIRECTOR
Capone Mark Christopher
Purchase · 2.8K shares
2026-08-15

MOST RECENT ANALYST GRADES

GRADE SUMMARY
EQUAL WEIGHT 1
1 GRADES IN THE LAST 12 MONTHS
Wells Fargo EQUAL WEIGHT

SECTORS PEERS

PEERPRICE
VPG$62.55COMPARE
PUBM$16.82COMPARE
LPTH$11.23COMPARE
GRVY$75.16COMPARE
XRX$3.06COMPARE
EGAN$7.40COMPARE
GDEV$10.87COMPARE
GRRR$14.41COMPARE